SUN 0597

Drug Profile

SUN 0597

Alternative Names: S-0597; S-597; SPARC-1316; SUN-597; SUN-S597; SUN0597

Latest Information Update: 22 Apr 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sun Pharma Advanced Research Company
  • Class Anti-inflammatories; Glucocorticoids
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Asthma
  • Preclinical Atopic dermatitis
  • No development reported Allergic conjunctivitis; Inflammation; Psoriasis; Seasonal allergic rhinitis

Most Recent Events

  • 27 Jul 2015 No recent reports on development identified - Phase-I for Inflammation (In volunteers) in India (Intranasal)
  • 27 Jul 2015 No recent reports on development identified - Phase-II for Seasonal allergic rhinitis in Germany (Intranasal)
  • 10 Jun 2015 Preclinical trials in Atopic dermatitis and Psoriasis in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top